Efficacy and safety of long-acting injectable risperidone in patients with schizophrenia

被引：0
|
作者：
Bouhours, P
Schreiner, A
Rendall, MR
机构：
[1] Janssen Cilag, Issy Les Moulineaux, France
[2] Janssen Cilag, Med & Sci Affairs, Neuss, Germany
[3] Janssen Cilag, High Wycombe, Bucks, England
来源：
SCHIZOPHRENIA RESEARCH | 2004年 / 67卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：170 / 171
页数：2
相关论文
共 50 条
  • [1] Long-acting injectable risperidone: Efficacy and safety
    Kane, JM
    Eerdekens, M
    Keith, SJ
    Lesem, M
    Karcher, K
    Lindenmayer, JP
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S325 - S325
  • [2] Obese patients with schizophrenia and schizoaffective disorder: Efficacy of injectable long-acting risperidone
    Permuy, RT
    Turner, MS
    Bouhours, P
    [J]. SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 175 - 175
  • [3] Long-acting injectable risperidone: Efficacy and safety of the first long-acting atypical antipsychotic
    Kane, JM
    Eerdekens, M
    Lindenmayer, JP
    Keith, SJ
    Lesem, M
    Karcher, K
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (06): : 1125 - 1132
  • [4] Risperidone Long-Acting Injection: Safety and Efficacy in Elderly Patients with Schizophrenia
    Catalan, Rosa
    Penades, Rafael
    [J]. JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE, 2011, 3 : 95 - 105
  • [5] Improved efficacy and safety in Danish patients treated with risperidone long-acting injectable
    Glue, P
    Lublin, H
    Refshammer, C
    Lex, A
    Lang-Jensen, L
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S402 - S403
  • [6] Long-acting injectable risperidone for the treatment of schizophrenia
    Moeller, Hans-Juergen
    [J]. DRUGS, 2007, 67 (11) : 1541 - 1566
  • [7] Effectiveness of long-acting injectable risperidone in the Korean schizophrenia patients
    Kim, H.
    Hong, J.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S456 - S456
  • [8] Effectiveness of long-acting injectable risperidone in the Korean schizophrenia patients
    Ciwoniuk, M.
    Godlewska, B. R.
    Olajossy-Hilkesberger, L.
    Olajossy, M.
    Marmurowska-Michalowska, H.
    Limon, J.
    Landowski, J.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S456 - S457
  • [9] Paliperidone Palmitate versus Risperidone Long-Acting Injectable in Patients with Schizophrenia: A Meta-Analysis of Efficacy and Safety
    Zhao, Mingjun
    Qin, Bin
    Mao, Yage
    Zhang, Yang
    Zhao, Ruisheng
    Wang, Aiqin
    Wang, Hailing
    Zhao, Jianting
    Wang, Changhong
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2023, 19 : 749 - 757
  • [10] Proven maintained efficacy and safety in patients with paranoid schizophrenia after direct switch to risperidone long-acting injectable
    Parellada, E
    Kissling, W
    Bouhours, F
    Gallhofer, B
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S402 - S402
12345